Examiner: INAM, SAHAR

Tech Center 1600 • Art Units: 1622

This examiner grants 100% of resolved cases

Performance Statistics

100.0%

Allow Rate

+40.0% vs TC avg

Total Applications

+0.0%

Interview Lift

907

Avg Prosecution Days

Based on 1 resolved cases, 2023–2026

§101 Eligibility

§102 Novelty

100.0%

§103 Obviousness

§112 Clarity

App #	Title	Status	Assignee
18524124	METHODS OF TREAMENT	Non-Final OA	Arena Pharmaceuticals, Inc.
18559992	USES AND METHODS FOR RECURRENT PRIMARY CNS NEOPLASMS	Non-Final OA	CHIMERIX, INC.
18475312	USE OF METHYLAMINOCOLCHICINE AND SALT THEREOF	Non-Final OA	Shenyang Pharmaceutical University

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.